1,188 filings
Page 4 of 60
8-K
5v4269e0e vvaiy6dm
2 Mar 20
VIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of
7:43am
4
kt5bv
24 Feb 20
VIVUS / HERM ROSENMAN ownership change
6:07pm
4
e609ya 1hj
24 Feb 20
VIVUS / Jorge MD Plutzky ownership change
6:06pm
4
plg40dn 8q6tjog7
24 Feb 20
VIVUS / David Y Norton ownership change
6:06pm
4
g3j9r6qk02zvcl
24 Feb 20
VIVUS / THOMAS BRAXTON KING ownership change
6:06pm
4
ii0whk i49
24 Feb 20
VIVUS / EDWARD A KANGAS ownership change
6:05pm
4
ks2ukg4wmr
24 Feb 20
VIVUS / Karen E. Ferrell ownership change
6:05pm
8-K
6sa5vpr
21 Feb 20
Departure of Directors or Certain Officers
4:05pm
8-K
5rarj5elppz64t oq6e9
19 Feb 20
VIVUS Announces Commercial Launch of Qsymia®in the Republic of Korea Establishing New Royalty Revenue Stream
7:35am
SC 13G/A
1oi0jt ivldv1
13 Feb 20
Vivus Inc
12:00am
8-K
sdkbt
5 Feb 20
VIVUS Receives U.S. Food and Drug Administration Approval for Improved Formulation of PANCREAZE® with a 36-Month Shelf Life
7:35am
SC 13G
tt9yk5b9klq7
4 Feb 20
Beneficial ownership report
4:03pm
4
wotvg
31 Jan 20
VIVUS / John P. Amos ownership change
5:25pm
4
2udwp4la
31 Jan 20
VIVUS / Mark K Oki ownership change
5:25pm
4
a7xxyqoo5yk jt
31 Jan 20
VIVUS / John L Slebir ownership change
5:24pm
4
qq6vurmrqm
31 Jan 20
VIVUS / Santosh T Varghese ownership change
5:23pm
8-K
jifub nvj2
31 Jan 20
Departure of Directors or Certain Officers
4:35pm
8-K
szbfrp2g9
7 Jan 20
Other Events
7:35am
8-A12B
niexmu1uhg
31 Dec 19
Registration of securities on exchange
7:50am